Frequent FDA inspections slow down Indian pharma exports, says GV Prasad
Posted by
www.biotecnika.org
GV Prasad, Chairman, CII National Committee on Pharmaceuticals said
that everybody should up their game in terms of quality, systems,
discipline, integrity of data. All there are important things for the
industry. He added that the effect of frequent inspections of Indian
pharma manufacturing plants by the FDA and measures to be taken to
reduce the impact.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/frequent-fda-inspections-slow-down-indian-pharma-exports-says-gv-prasad/articleshow/72109876.cms
Subscribe to:
Post Comments (Atom)
Post a Comment